OpportunityJOBPublic signalyesterday
CSO
Shennon Biotechnologies is hiring for this role on its own job board, after raising $12M.
Who they want
Approach preferences not yet specified
Shennon Biotechnologies
Why now
Where Shennon Biotechnologies is today
Shennon Biotechnologies announced a funding round of $12M on 14 September 2026.
Latest round
Undisclosed
Amount
$12M
Announced
14 September 2026
Headquarters
San Francisco, USA
Sector
Biotech & Pharma
Growth stage
Growth
Investors
Not stated
Also participating
Not stated
Relevant leadership
CEO Cyril Konto
Momentum AfterRaise intelligence
AfterRaise Score
62
Building momentum
1 funding signal in the last 90 days
Arriving with the signals layer
- Hiring momentum Open roles and hiring pace
- Market expansion New offices and new countries
- Leadership Executive appointments
- Product activity Launches and releases
In their own words
What Shennon Biotechnologies says it is doing
Public signal Described in the funding announcement as "biotechnology company developing precision immunotherapies for cancer". Source
ProductResearch and development
Public signal Read from the company's own description of what the funding supports.
Since the raise
What has happened since
- 14 September 2026$12M raisedInvestors not stated in the announcement.
Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.
What may happen next
What this raise could create
AfterRaise intelligenceNot a statement of fact
What may happen next
- Product launches and new tiers
- Product leadership hiring
- Research programme expansion
- Scientific team growth
Opportunities this could create
- Clinical operations
- Scientific hiring
- Licensing and BD partnerships
- Product leadership
- Design partners
Based on the Biotech & Pharma sector, a Growth round and the priorities the company itself set out. Not a statement of fact.
Medium momentum3 connected signals
- 14 September 2026$12M round announced
- 14 September 2026Stated priority: product
- 14 September 2026Stated priority: research and development
High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.
Open to
What Shennon Biotechnologies is open to
Not yet specified
Shennon Biotechnologies has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.
Work here? Set your preferencesOpportunities
Ways to work with Shennon Biotechnologies
OpportunityJOBPublic signal6 days ago
Senior Scientist in Antibody Development
Shennon Biotechnologies is hiring for this role on its own job board, after raising $12M.
Who they want
Approach preferences not yet specified
OpportunityJOBPublic signal21 days ago
Lab Technician for Microfabrication (part-time)
Shennon Biotechnologies is hiring for this role on its own job board, after raising $12M.
Who they want
Approach preferences not yet specified
OpportunityJOBPublic signal3 months ago
Join our Talent Pool!
Shennon Biotechnologies is hiring for this role on its own job board, after raising $12M.
Who they want
Approach preferences not yet specified
Helpful contributors
People who have contributed here
Nobody yet
When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.
Do you work at Shennon Biotechnologies?
Reserve your company page.
This page was created from publicly available information. When verified company accounts open, your team will be able to correct your profile, tell the market what you actually need and control how people approach you.
Someone else requesting access does not give them ownership. Every company administrator is verified before access is granted.
The first 1,000 verified funded companies join the Founding 1,000 free for life and keep Founding Company status permanently.
Also moving